GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Agenus Inc. (AGEN) [hlAlert]

Rating:
Buy AGEN
up 59.95 %

Agenus Inc. (AGEN) rated Buy with price target $9 by MLV & Co

Posted on: Friday,  Jan 9, 2015  2:25 PM ET by MLV & Co

MLV & Co rated Buy Agenus Inc. (NASDAQ: AGEN) on 01/09/2015. Previously MLV & Co rated Buy Agenus Inc. (NASDAQ: AGEN) on
03/14/2014., when the stock price was $4.32. Since then, Agenus Inc. has gained 59.95% as of 01/21/2016's recent price of $6.91.
If you would have followed the previous MLV & Co's recommendation on AGEN, you would have gained 59.95% of your investment in 678 days.

Antigenics Inc. is engaged in the discovery and development of a family of novel immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight disease. The company is evaluating the lead immunotherapeutic, Oncophage, in six separate phase II or phase I/II clinical trials in four different cancers. The company is also developing immunotherapeutics to treat infectious diseases, such as genital herpes, and autoimmune disorders, such as diabetes and multiple sclerosis.

MLV & Co is a boutique investment bank and institutional broker-dealer focused on providing independent financial advice and unique capital markets expertise to corporate and institutional clients in capital intensive industries such as metals and mining, life sciences, energy and real estate. With a focus on raising money efficiently for clients, MLV has rapidly become a leader in the At-the-Market(ATM) transaction market.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/9/2015 2:25 PM Buy
None
5.41 9.00
as of 8/27/2015
1 Week down  -10.60 %
1 Month down  -19.65 %
3 Months down  -1.70 %
1 YTD up  27.72 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/14/2014 8:25 AM Buy
None
4.32 11.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy